Business
Sanofi-Aventis makes $18.5-billion cash offer for Genzyme
Aug. 30, 2010
A union would create the world’s third-largest drug maker. The target says the hostile offer is bad for shareholders.
Jan. 27, 2004
Sanofi-Aventis said U.S. regulators approved a long-acting version of sleep aid Ambien, which loses patent protection next year.
Sept. 7, 2005
Science & Medicine
The company releases study results indicating that its Acomplia helps patients control blood sugar and lose weight.
June 13, 2005
Business of Law Trends, Updates Visionaries and The In-House Counsel Awards Recap
Brian Sun is a seasoned trial lawyer, experienced in complex business litigation, white-collar criminal defense, and multi-jurisdictional investigation matters.
June 25, 2023
EpiPen maker Mylan has finalized a $465-million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade — charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government.
Aug. 17, 2017
World & Nation
In the second such recall this season, manufacturer MedImmune says the vaccine has lost potency since it was made. ‘This is not a safety issue,’ a U.S. official says.
Sept. 16, 2014
Swine flu deaths rise to nearly 5,000, Glaxo says kids may only need 1 vaccine dose.
Archives
A note from Ben Vereen
March 15, 2014
Lots of people in the healthcare field heaved a sigh of relief last week when President Trump nominated Scott Gottlieb, a physician, venture investor and former official of the Food and Drug Administration, to be the FDA’s next commissioner.
March 16, 2017